In summary, we have originally proved the new pharmacological effects of PQQ, which could ameliorate the obesity-related male subfertility via regulating PCSK9-NLRP3 crosstalk. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.